U.S. Rep. Steve Cohen (D-TN) introduced a bill Tuesday that would change federal law so that the director of the Office of National Drug Control Policy (ONDCP), commonly known as the “drug czar,” is no longer prohibited from studying the legalization of marijuana and no longer required to oppose attempts to legalize marijuana for medical or broader adult use.

Specifically, H.R. 4046, the Unmuzzle the Drug Czar Act of 2014, would amend the Office of National Drug Control Policy Reauthorization Act of 1998 to remove the following language from the obligations of the director:

(12) shall ensure that no Federal funds appropriated to the Office of National Drug Control Policy shall be expended for any study or contract relating to the legalization (for a medical use or any other use) of a substance listed in schedule I of [the Controlled Substances Act] and.take such actions as necessary to oppose any attempt to legalize the use of a substance (in any form) that –

(A) is listed in schedule I of section 812 of this title; and

(B) has not been approved for use for medical purposes by the Food and Drug Administration;

Rep. Cohen and other members of the House Committee on Oversight and Government Reform slammed the ONDCP during a hearing last week. Rep. Cohen chided the office for failing to address the National Institute on Drug Abuse’s obstruction of research into the medical benefits of marijuana. Rep. Earl Blumenauer (D-OR) criticized it for relying on marijuana “propaganda.” ONDCP Deputy Director Michael Botticelli drew criticism for refusing to acknowledge that marijuana poses less potential harm to the consumer than heroin or methamphetamine.